Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 42%
Hold 42%
Sell 8%
Strong Sell 0%

Bulls say

Henry Schein is well-positioned for growth with its strong presence in the dental and medical industries, strategic focus on office-based healthcare, and plans for mergers and acquisitions. Despite potential challenges, such as low reimbursement rates, the company has a solid financial outlook and remains positive about its future. Risks such as cybersecurity attacks and supply chain disruptions should be monitored, but the company has a target price of $97 and a strong potential for international expansion in addition to their solid US presence.

Bears say

Henry Schein is facing numerous headwinds from a slower global economic environment, the potential impact of the ongoing war in Iran, and increasing competition within the healthcare distribution industry. Additionally, the company's lower projected revenue growth and EBITDA margin compared to its sub-sector peers indicate potential struggles in maintaining its market leadership position. Its significant debt load also poses a risk to its ability to invest in future growth opportunities.

Henry Schein (HSIC) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 42% recommend Buy, 42% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 12 analysts, Henry Schein (HSIC) has a Hold consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.